InvestorsHub Logo
Followers 65
Posts 2029
Boards Moderated 0
Alias Born 10/31/2017

Re: Kaizenman post# 430331

Wednesday, 12/29/2021 1:47:37 AM

Wednesday, December 29, 2021 1:47:37 AM

Post# of 701565
Ionis basically structured itself in the way you are suggesting. They sold disease state rights for antisense development to a variety of biopharma. They launched one themseleves and have partnerships that prevent them from being taken out.

This is old school biotech, back when the start ups made deals for cash instead of selling a bunch of stock. They tried to lock in three or four deals with poisen pills that made anyone takeover lose a bunch of assets.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News